Kepos Capital’s Medifast MED Stock Holding History

Kepos Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,501	Closed	-$554K	–	382
2018 Q3	$554K	Buy	+2,501	New	+$507K	0.03%	282

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Kepos Capital's MED Position: Q4 2018 in Review

Kepos Capital sold out of Medifast (MED) in Q4 2018, closing a stake of 2,501 shares — an estimated $554K sold.

Kepos Capital first reported a position in MED in Q3 2018 and held it in 1 quarter. The position peaked at $554K in Q3 2018. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Kepos Capital reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Kepos Capital sold 2,501 Medifast shares in Q4 2018, an estimated $554K.
Kepos Capital first reported a position in Medifast in Q3 2018 and held it in 1 quarter.
Kepos Capital's Medifast position peaked at $554K in Q3 2018.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Kepos Capital's 13F filing for Q4 2018, filed 13 Feb 2019.